French Diatos Elected Among the 15 Emerging Biotech Companies 2004 for Its Innovative Technologies and International Developmen
FierceBiotech Editor-in-chief John D. Carroll lauded Diatos's research efforts in 2004, saying "Diatos has pioneered two technologies for cancer and other life-threatening diseases, and is preparing to advance its innovative therapeutic products into clinical trials."
"FierceBiotech is well-known for its coverage of biotech trends and successful business strategies," said Dr. John Tchelingerian, President and Chief Executive Officer of Diatos. "Being selected as a member of The Fierce 15 is an honor that recognizes Diatos's emerging international presence in the biotech industry."
The Fierce 15 celebrates the spirit of being "fierce" - daring to be innovative and aggressive, even in an industry with a long time-to-market. The list of Fierce 15 companies is available in today's issue of FierceBiotech and on their web site at www.fiercebiotech.com.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.